ARGENT BIOPHARMA LIMITED financial statements, including revenue, expenses, profit, and loss
The total revenue of RGT for the last semiannual is 599.53 k AUD, and it's 17.30% lower compared to the previous semiannual. The net income of H1 24 is -7.08 M AUD.